RECOVERY - 2010 Adult Vaccine Contract

The proposed contract will be funded through the American Recovery and Reinvestment Act of 2009. All vaccines acquired through this contract are subject to purchase with appropriated funds allocated through the American Recovery and Reinvestment Act (ARRA).

The Centers for Disease Control and Prevention (CDC) will issue a Request for Proposals (RFP) for a multiple award, Indefinite Delivery, Indefinite Quantity (IDIQ), Firm Fixed Price (FFP) contract to purchase standard commercial adult vaccines that have been manufactured under a current product license issued by the U.S Food and Drug Administration (FDA). The CDC anticipates awarding multiple contracts to various vaccine manufacturers and/or distributors for the following vaccines:
(1) Hepatitis A adult vaccine
(2) Hepatitis B adult vaccine
(3) Combination Hepatitis A&B vaccine
(4) Pneumococcal Polysaccharide vaccine
(5) Tetanus and Diphtheria Toxoids vaccine for adults
(6) Herpes Zoster vaccine
(7) Tetanus Toxoid, Reduced Diphtheria Toxoid with Acellular Pertussis Adsorbed
(8) Measles, Mumps, and Rubella
(9) Meningococcal Conjugate
(10) Bivalent / Quadrivalent Human Papillomavirus types 6, 11, 16, 18 recombinant vaccine
(11) Varicella

Vaccines purchased through this contracting vehicle are acquired for the CDC / National Center for Immunization and Respiratory Disease's (NCRID) adult vaccine program. The CDC NCIRD provides vaccines for state run health departments across all fifty states; designated city or municipal public health care programs, and former U.S Territories - as provided under Section 317(j) of the Public Health Service Act. Information regarding maximum estimated quantities, minimum order sizes, and shelf life (post dated) requirements are listed in the RFP. Vaccines shall be shipped F.O.B. destination. The contract period of performance is twelve (12) consecutive months, beginning on or about 7/1/2010. Offerors must provide evidence of current Food and Drug Administration (FDA) product licenses for all vaccines. The Request for Proposal (RFP), Solicitation Number: 2010-N-11987, will be posted on the Government wide Point of Entry (GPE) - Federal Business Opportunities ( www.fedbizopps.gov ) - on or about 4/9/2010. All responsible sources may submit a proposal, which shall be considered by the agency if received on or before the designated response time and date as specified in the RFP.

Respondents will assume all financial costs for preparing a response to this notice. The U.S. Government assumes no financial obligation for the preparation and distribution of prepared responses.

The proposed contract will be funded through the American Recovery and Reinvestment Act of 2009. All vaccines acquired through this contract are subject to purchase with appropriated funds allocated through the American Recovery and Reinvestment Act (ARRA).

The Centers for Disease Control and Prevention (CDC) will issue a Request for Proposals (RFP) for a multiple award, Indefinite Delivery, Indefinite Quantity (IDIQ), Firm Fixed Price (FFP) contract to purchase standard commercial adult vaccines that have been manufactured under a current product license issued by the U.S Food and Drug Administration (FDA). The CDC anticipates awarding multiple contracts to various vaccine manufacturers and/or distributors for the following vaccines:
(1) Hepatitis A adult vaccine
(2) Hepatitis B adult vaccine
(3) Combination Hepatitis A&B vaccine
(4) Pneumococcal Polysaccharide vaccine
(5) Tetanus and Diphtheria Toxoids vaccine for adults
(6) Herpes Zoster vaccine
(7) Tetanus Toxoid, Reduced Diphtheria Toxoid with Acellular Pertussis Adsorbed
(8) Measles, Mumps, and Rubella
(9) Meningococcal Conjugate
(10) Bivalent / Quadrivalent Human Papillomavirus types 6, 11, 16, 18 recombinant vaccine
(11) Varicella

Vaccines purchased through this contracting vehicle are acquired for the CDC / National Center for Immunization and Respiratory Disease's (NCRID) adult vaccine program. The CDC NCIRD provides vaccines for state run health departments across all fifty states; designated city or municipal public health care programs, and former U.S Territories - as provided under Section 317(j) of the Public Health Service Act. Information regarding maximum estimated quantities, minimum order sizes, and shelf life (post dated) requirements are listed in the RFP. Vaccines shall be shipped F.O.B. destination. The contract period of performance is twelve (12) consecutive months, beginning on or about 7/1/2010. Offerors must provide evidence of current Food and Drug Administration (FDA) product licenses for all vaccines. The Request for Proposal (RFP), Solicitation Number: 2010-N-11987, will be posted on the Government wide Point of Entry (GPE) - Federal Business Opportunities ( www.fedbizopps.gov ) - on or about 4/1/2010. All responsible sources may submit a proposal, which shall be considered by the agency if received on or before the designated response time and date as specified in the RFP.